Bertram Hartmann

Summary

Publications

  1. doi request reprint Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition
    Bertram Hartmann
    Medical Department I, Nephrology Section, Ulm University, Ulm, Germany
    Ther Drug Monit 35:233-9. 2013
  2. doi request reprint Explicit solution of integrated 1 - exp equation for predicting accumulation and decline of concentrations for drugs obeying nonlinear saturation kinetics
    Frieder Keller
    Nephrology, Medical Faculty, University of Ulm, Ulm, Germany
    Ther Drug Monit 31:783-5. 2009
  3. doi request reprint [Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function]
    Sebastian Maus
    Nephrologie, Medizinische Fakultat, Universitat Ulm, Ulm, Germany
    Wien Klin Wochenschr 122:479-85. 2010
  4. ncbi request reprint Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation
    Frieder Keller
    Division of Nephrology, Department of Internal Medicine I, University Hospital Ulm, Albert Einstein Allee 23, Ulm, Germany
    Ann Transplant 17:52-8. 2012
  5. doi request reprint Time of effect duration and administration interval for sitagliptin in patients with kidney failure
    Frieder Keller
    Division of Nephrology, Department of Internal Medicine 1, University Hospital, Albert Einstein Allee 23, 89070, Ulm, Germany
    Eur J Drug Metab Pharmacokinet 39:77-85. 2014
  6. pmc Drug therapy in patients with chronic renal failure
    Bertram Hartmann
    Universitat Ulm, Medizinische Fakultat, Nephrologie, Ulm, Germany
    Dtsch Arztebl Int 107:647-55; quiz 655-6. 2010
  7. doi request reprint Mean residence time as estimated from cropped and truncated moments
    Frieder Keller
    Nephrology, Medical Faculty, University of Ulm, Ulm, Germany
    Arzneimittelforschung 59:377-81. 2009

Collaborators

Detail Information

Publications7

  1. doi request reprint Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition
    Bertram Hartmann
    Medical Department I, Nephrology Section, Ulm University, Ulm, Germany
    Ther Drug Monit 35:233-9. 2013
    ....
  2. doi request reprint Explicit solution of integrated 1 - exp equation for predicting accumulation and decline of concentrations for drugs obeying nonlinear saturation kinetics
    Frieder Keller
    Nephrology, Medical Faculty, University of Ulm, Ulm, Germany
    Ther Drug Monit 31:783-5. 2009
    ....
  3. doi request reprint [Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function]
    Sebastian Maus
    Nephrologie, Medizinische Fakultat, Universitat Ulm, Ulm, Germany
    Wien Klin Wochenschr 122:479-85. 2010
    ..Our intention was to assess knowledge and requirements related to drug dose adjustment in patients with impaired kidney function...
  4. ncbi request reprint Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation
    Frieder Keller
    Division of Nephrology, Department of Internal Medicine I, University Hospital Ulm, Albert Einstein Allee 23, Ulm, Germany
    Ann Transplant 17:52-8. 2012
    ....
  5. doi request reprint Time of effect duration and administration interval for sitagliptin in patients with kidney failure
    Frieder Keller
    Division of Nephrology, Department of Internal Medicine 1, University Hospital, Albert Einstein Allee 23, 89070, Ulm, Germany
    Eur J Drug Metab Pharmacokinet 39:77-85. 2014
    ..90 is 51 h in kidney failure, only 3 h longer than the latter administration interval (+6 %). We conclude that our general equation can be applied to rapidly calculate the specific time of effect duration for the different dose schedules...
  6. pmc Drug therapy in patients with chronic renal failure
    Bertram Hartmann
    Universitat Ulm, Medizinische Fakultat, Nephrologie, Ulm, Germany
    Dtsch Arztebl Int 107:647-55; quiz 655-6. 2010
    ..This is frequently overlooked because of the creatinine-blind range in which early stages of renal failure are often hidden. Chronic kidney disease is divided into 5 stages (CKD 1 to 5)...
  7. doi request reprint Mean residence time as estimated from cropped and truncated moments
    Frieder Keller
    Nephrology, Medical Faculty, University of Ulm, Ulm, Germany
    Arzneimittelforschung 59:377-81. 2009
    ..1 h). For the complex kinetics of raloxifene (CAS 82640-04-8) it was seen that the cropping and truncation errors are non additive...